heart failure

FDA Grants Breakthrough Designation for Heart Failure Device
FDA Grants Breakthrough Designation for Heart Failure Device
Medical Devices and Diagnostics Industry
VisCardia
VisOne
heart failure
devices
FDA
Flag link:
ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data
ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data
Fierce Biotech
ACC
Merck
Bayer
heart failure
vericiguat
clinical trials
Flag link:
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
EP Vantage
Bayer
Merck
vericiguat
heart failure
AKR-001
Akero Therapeutics
clinical trials
NASH
Flag link:
AstraZeneca kicks off 2020 with double win in US and China
AstraZeneca kicks off 2020 with double win in US and China
Pharmaforum
AstraZeneca
FDA
Farxiga
heart failure
China
Lokelma
hyperkalemia
Flag link:
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
Flag link:
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
AstraZeneca
diabetes
type 2 diabetes
heart failure
Flag link:
AstraZeneca, Novoheart to Co-Develop New Heart Model
AstraZeneca, Novoheart to Co-Develop New Heart Model
Xconomy
AstraZeneca
Novoheart
heart-in-a-jar
heart failure
Flag link:
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
Flag link:
Janssen taps wearable tech in Invokana heart failure trial
Janssen taps wearable tech in Invokana heart failure trial
Pharmaforum
JNJ
Janssen
Invokana
heart failure
wearables
real world evidence
clinial trials
Flag link:
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Flag link:
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
AstraZeneca
Farxiga
type 1 diabetes
heart failure
Flag link:
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
Fierce Pharma
AstraZeneca
Farxiga
EASD
heart failure
Flag link:
AstraZeneca diabetes drug granted fast track status for heart failure treatment
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Flag link:
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
Fierce Pharma
AstraZeneca
Farxiga
drug reps
heart failure
Flag link:
Heart failure results could unlock key market for Farxiga – AZ
Heart failure results could unlock key market for Farxiga – AZ
Pharmaforum
AstraZeneca
heart failure
diabetes
Farxiga
Flag link:
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Novartis
heart failure
Entresto
clinical trials
ESC
European Society of Cardiology
Flag link:
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
The Hill
FDA
heart failure
drug development
Flag link:

Pages